-
1
-
-
0028221989
-
Topiramate: Preclinical evaluation of a structurally novel anticonvulsant
-
R.P. Shank, J.F. Gardocki, and J.L. Vaught et al. Topiramate: preclinical evaluation of a structurally novel anticonvulsant Epilepsia 35 1994 450 460
-
(1994)
Epilepsia
, vol.35
, pp. 450-460
-
-
Shank, R.P.1
Gardocki, J.F.2
Vaught, J.L.3
-
2
-
-
0033781367
-
Influence of topiramate in the regulation of energy balance
-
D. Richard, J. Ferland, J. Lalonde, P. Samson, and Y. Deshaies Influence of topiramate in the regulation of energy balance Nutrition 16 2000 961 966
-
(2000)
Nutrition
, vol.16
, pp. 961-966
-
-
Richard, D.1
Ferland, J.2
Lalonde, J.3
Samson, P.4
Deshaies, Y.5
-
3
-
-
0032748141
-
Role of hypothalamic neuropeptide y in feeding and obesity
-
D.R. Gehlert Role of hypothalamic neuropeptide Y in feeding and obesity Neuropeptides 33 1999 329 338
-
(1999)
Neuropeptides
, vol.33
, pp. 329-338
-
-
Gehlert, D.R.1
-
4
-
-
15844431544
-
Fat regulation. Prime time for neuropeptide y
-
R. Howlett Fat regulation. Prime time for neuropeptide Y Nature 382 1996 113
-
(1996)
Nature
, vol.382
, pp. 113
-
-
Howlett, R.1
-
5
-
-
0035282352
-
Topiramate in refractory partial seizures in children, adolescents and young adults: A multicentric open trial
-
G. Coppola, G. Caliendo, M.M. Terracciano, S. Buono, L. Pellegrino, and A. Pascotto Topiramate in refractory partial seizures in children, adolescents and young adults: a multicentric open trial Epilepsy Res 43 2001 255 260
-
(2001)
Epilepsy Res
, vol.43
, pp. 255-260
-
-
Coppola, G.1
Caliendo, G.2
Terracciano, M.M.3
Buono, S.4
Pellegrino, L.5
Pascotto, A.6
-
6
-
-
0033898403
-
Topiramate in refractory epilepsy: A prospective observational study
-
L.J. Stephen, G.J. Sills, and M.J. Brodie Topiramate in refractory epilepsy: a prospective observational study Epilepsia 41 2000 977 980
-
(2000)
Epilepsia
, vol.41
, pp. 977-980
-
-
Stephen, L.J.1
Sills, G.J.2
Brodie, M.J.3
-
7
-
-
36649019378
-
Weight issues for people with epilepsy - A review
-
E. Ben-Menachem Weight issues for people with epilepsy - a review Epilepsia 48 2007 42 45
-
(2007)
Epilepsia
, vol.48
, pp. 42-45
-
-
Ben-Menachem, E.1
-
9
-
-
67651152714
-
Atherosclerotic risk among children taking antiepileptic drugs
-
T. Jakubus, M. Michalska-Jakubus, K. Lukawski, A. Janowska, and S.J. Czuczwar Atherosclerotic risk among children taking antiepileptic drugs Pharmacol Rep 61 2009 411 423
-
(2009)
Pharmacol Rep
, vol.61
, pp. 411-423
-
-
Jakubus, T.1
Michalska-Jakubus, M.2
Lukawski, K.3
Janowska, A.4
Czuczwar, S.J.5
-
10
-
-
0043181917
-
Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures
-
E. Ben-Menachem, O. Henriksen, and M. Dam et al. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures Epilepsia 37 1996 539 543
-
(1996)
Epilepsia
, vol.37
, pp. 539-543
-
-
Ben-Menachem, E.1
Henriksen, O.2
Dam, M.3
-
11
-
-
0033594522
-
A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group
-
V. Biton, G.D. Montouris, and F. Ritter et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group Neurology 52 1999 1330 1337
-
(1999)
Neurology
, vol.52
, pp. 1330-1337
-
-
Biton, V.1
Montouris, G.D.2
Ritter, F.3
-
12
-
-
0034468266
-
Safety and tolerability of topiramate in children
-
P.M. Levisohn Safety and tolerability of topiramate in children J Child Neurol 15 2000 22 26
-
(2000)
J Child Neurol
, vol.15
, pp. 22-26
-
-
Levisohn, P.M.1
-
13
-
-
0346593400
-
A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity
-
G.A. Bray, P. Hollander, and S. Klein et al. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity Obes Res 11 2003 722 733
-
(2003)
Obes Res
, vol.11
, pp. 722-733
-
-
Bray, G.A.1
Hollander, P.2
Klein, S.3
-
14
-
-
33846416927
-
The effect of topiramate on energy balance in obese men: A 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension
-
A. Tremblay, J.P. Chaput, and S. Bérubé-Parent et al. The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension Eur J Clin Pharmacol 63 2007 123 134
-
(2007)
Eur J Clin Pharmacol
, vol.63
, pp. 123-134
-
-
Tremblay, A.1
Chaput, J.P.2
Bérubé-Parent, S.3
-
15
-
-
42449091913
-
Topiramate, nutrition and weight change: A prospective study
-
K.M. Klein, F. Theisen, and S. Knake et al. Topiramate, nutrition and weight change: a prospective study J Neurol Neurosurg Psychiatry 79 2008 590 593
-
(2008)
J Neurol Neurosurg Psychiatry
, vol.79
, pp. 590-593
-
-
Klein, K.M.1
Theisen, F.2
Knake, S.3
-
16
-
-
34547563926
-
Long-term patterns of weight changes during topiramate therapy: An observational study
-
S.H. El Yaman, S.M. Mroueh, D.D. Sinno, and M.A. Mikati Long-term patterns of weight changes during topiramate therapy: an observational study Neurology 69 2007 310 311
-
(2007)
Neurology
, vol.69
, pp. 310-311
-
-
El Yaman, S.H.1
Mroueh, S.M.2
Sinno, D.D.3
Mikati, M.A.4
-
17
-
-
4344641323
-
Changes in body mass index during long-term topiramate therapy in paediatric epilepsy patients - A retrospective analysis
-
E. Reiter, M. Feucht, E. Hauser, M. Freilinger, and R. Seidl Changes in body mass index during long-term topiramate therapy in paediatric epilepsy patients - a retrospective analysis Seizure 13 2004 491 493
-
(2004)
Seizure
, vol.13
, pp. 491-493
-
-
Reiter, E.1
Feucht, M.2
Hauser, E.3
Freilinger, M.4
Seidl, R.5
-
18
-
-
1642565342
-
Additive effects of leptin and topiramate in reducing fat deposition in lean and obese ob/ob mice
-
J. Lalonde, P. Samson, S. Poulin, Y. Deshaies, and D. Richard Additive effects of leptin and topiramate in reducing fat deposition in lean and obese ob/ob mice Physiol Behav 80 2004 415 420
-
(2004)
Physiol Behav
, vol.80
, pp. 415-420
-
-
Lalonde, J.1
Samson, P.2
Poulin, S.3
Deshaies, Y.4
Richard, D.5
-
19
-
-
68649129107
-
Effects of topiramate on weight and metabolism in children with epilepsy
-
H.F. Li, Y. Zou, Z.Z. Xia, F. Gao, J.H. Feng, and C.W. Yang Effects of topiramate on weight and metabolism in children with epilepsy Acta Paediatr 98 2009 1521 1525
-
(2009)
Acta Paediatr
, vol.98
, pp. 1521-1525
-
-
Li, H.F.1
Zou, Y.2
Xia, Z.Z.3
Gao, F.4
Feng, J.H.5
Yang, C.W.6
-
20
-
-
0042840536
-
Predictors of weight loss in adults with topiramate-treated epilepsy
-
E. Ben-Menachem, M. Axelsen, E.H. Johanson, A. Stagge, and U. Smith Predictors of weight loss in adults with topiramate-treated epilepsy Obes Res 11 2003 556 562
-
(2003)
Obes Res
, vol.11
, pp. 556-562
-
-
Ben-Menachem, E.1
Axelsen, M.2
Johanson, E.H.3
Stagge, A.4
Smith, U.5
-
21
-
-
77951975951
-
Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: A double-blind, placebo-controlled trial
-
P.K. Narula, H.S. Rehan, K.E. Unni, and N. Gupta Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial Schizophr Res 118 2010 218 223
-
(2010)
Schizophr Res
, vol.118
, pp. 218-223
-
-
Narula, P.K.1
Rehan, H.S.2
Unni, K.E.3
Gupta, N.4
-
22
-
-
0003150278
-
An overview of the preclinical aspects of topiramate: Pharmacology, pharmacokinetics and mechanism of action
-
R.P. Shank, J.F. Gardocki, A.J. Streeter, and B.E. Maryanoff An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics and mechanism of action Epilepsia 41 2000 3 9
-
(2000)
Epilepsia
, vol.41
, pp. 3-9
-
-
Shank, R.P.1
Gardocki, J.F.2
Streeter, A.J.3
Maryanoff, B.E.4
-
23
-
-
0030852954
-
More clues from fat mice: Leptin acts as an opponent of the hypothalamic neuropeptide y system
-
C. Spitzweg, and A.E. Heufelder More clues from fat mice: leptin acts as an opponent of the hypothalamic neuropeptide Y system Eur J Endocrinol 136 1997 590 591
-
(1997)
Eur J Endocrinol
, vol.136
, pp. 590-591
-
-
Spitzweg, C.1
Heufelder, A.E.2
-
24
-
-
0041922327
-
Topiramate normalizes hippocampal NPY-LI in flinders sensitive line 'depressed' rats and upregulates NPY, galanin, and CRH-LI in the hypothalamus: Implications for mood-stabilizing and weight loss-inducing effects
-
H. Husum, D. Van Kammen, E. Termeer, G. Bolwig, and A. Mathé Topiramate normalizes hippocampal NPY-LI in flinders sensitive line 'depressed' rats and upregulates NPY, galanin, and CRH-LI in the hypothalamus: implications for mood-stabilizing and weight loss-inducing effects Neuropsychopharmacology 28 2003 1292 1299
-
(2003)
Neuropsychopharmacology
, vol.28
, pp. 1292-1299
-
-
Husum, H.1
Van Kammen, D.2
Termeer, E.3
Bolwig, G.4
Mathé, A.5
-
25
-
-
84868519081
-
Evaluation of appetite-stimulating hormones in prepubertal children with epilepsy during topiramate treatment
-
C. Okuyaz, O. Kursel, M. Komur, and L. Tamer Evaluation of appetite-stimulating hormones in prepubertal children with epilepsy during topiramate treatment Pediatr Neurol 47 2012 423 426
-
(2012)
Pediatr Neurol
, vol.47
, pp. 423-426
-
-
Okuyaz, C.1
Kursel, O.2
Komur, M.3
Tamer, L.4
-
26
-
-
79960343088
-
Topiramate-induced weight loss: A review
-
A. Verrotti, A. Scaparrotta, S. Agostinelli, S. Di Pillo, F. Chiarelli, and S. Grosso Topiramate-induced weight loss: a review Epilepsy Res 95 2011 189 199
-
(2011)
Epilepsy Res
, vol.95
, pp. 189-199
-
-
Verrotti, A.1
Scaparrotta, A.2
Agostinelli, S.3
Di Pillo, S.4
Chiarelli, F.5
Grosso, S.6
-
27
-
-
0033775875
-
Effect of topiramate on body weight and body composition of Osborne-Mendel rats fed a high-fat diet: Alterations in hormones, neuropeptide, and uncoupling-protein mRNAs
-
D.A. York, L. Singer, S. Thomas, and G.A. Bray Effect of topiramate on body weight and body composition of Osborne-Mendel rats fed a high-fat diet: alterations in hormones, neuropeptide, and uncoupling-protein mRNAs Nutrition 16 2000 967 975
-
(2000)
Nutrition
, vol.16
, pp. 967-975
-
-
York, D.A.1
Singer, L.2
Thomas, S.3
Bray, G.A.4
|